Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer

NCT00897871 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: etoposide phosphate
GENETIC: gene expression analysis
GENETIC: polymorphism analysis
OTHER: pharmacological study

Sponsor

Children's Cancer and Leukaemia Group